Derosa G, Cicero FGA, Gaddi A, Mugellini A, Ciccarelli L & Fogari R (2003): The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus
Given that there are now GLP-1 pills, I'm wondering if the adoption curve will change
Presently, there are no medications approved by the Federal Drug Administration (FDA) or European Medicines Agency (EMA) for the treatment of NAFLD or NASH, though as this review will detail, many agents are currently being studied in clinical trials
If you want to explore this option, consider reaching out to a local wellness provider who can guide you through the process safely and effectively
Wegovy is not automatically a reason for exclusion from blood or plasma donation